Liliana Bordeianou, MD, MPH
Division of General Surgery
Division of Colorectal Surgery
15 Parkman Street, WANG 460
Boston, MA 02114
lbordeianou@partners.org
phone: (617) 643-0541
fax: (617) 643-0548

Mass General / North Shore Center for Outpatient Care
104 Endicott St. Suite 200
Danvers, MA 01923
phone: (617) 643-0541
fax: (617) 643-0508

Clinical Background:

Degrees:
MD, Harvard Medical School
MPH, Harvard School of Public Health

Residency:
Massachusetts General Hospital, Boston, MA
Surgery

Fellowship:
University of Minnesota Hospitals, St. Paul, MN
Fellowship in Colon & Rectal Surgery
Administrative Chief Resident

Board Certifications:
Surgery, American Board of Surgery
Colorectal Surgery, American Board of Colon and Rectal Surgery

Clinical Interests:
Laparoscopy for colon and rectal cancer, Crohn's disease, ulcerative colitis and diverticulitis. Sphincter preservation techniques, including transanal endoscopic microsurgery. Treatment of fecal incontinence and rectal prolapse.

Research Interests:
Colon and rectal cancers, diverticular, inflammatory bowel and anorectal diseases, pelvic floor physiology and disorders.

Recent Publications:

1. Total Proctocolectomy with Ileoanal J-Pouch Reconstruction Utilizing the Hand-Assisted Laparoscopic Approach. Bordeianou L, Hodin R. J Gastrointest Surg. 2009 Jul 15. [Epub ahead of print]

2. Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery. Bordeianou L, Kunitake H, Shellito P, Hodin R. Int J Colorectal Dis. 2009 Oct 2. [Epub ahead of print]

3. Current thinking on recurrence: Does anastomotic surgical technique affect recurrence rates in Crohn's patients? Bordeianou L, Dursun A.Inflamm Bowel Dis. 2009 Sep 16. [Epub ahead of print]

4. Contained anastomotic leaks after colorectal surgery: are we too slow to act? Damrauer SM, Bordeianou L, Berger D. Arch Surg. 2009 Apr;144(4):333-8

5. In flux on infliximab: conflicting studies on surgical outcomes. Bordeianou L.Inflamm Bowel Dis. 2009 Oct;15(10):1605-6.

6. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L. J Gastrointest Surg. 2008 Oct;12(10):1730-6

7. Cystic pancreatic endocrine neoplasms: a distinct tumor type? Bordeianou L, Vagefi PA, Sahani D, Deshpande V, Rakhlin E, Warshaw AL, Fernández-del Castillo C. J Am Coll Surg. 2008 Jun;206(3):1154-8.

8. Anal resting pressures at manometry correlate with the Fecal Incontinence Severity Index and with presence of sphincter defects on ultrasound. Bordeianou L, Lee KY, Rockwood T, Baxter NN, Lowry A, Mellgren A, Parker S.Dis Colon Rectum. 2008 Jul;51(7):1010-4.

9. Bad news on glues: fibrin glue success rates in the treatment of anal fistulas. Bordeianou L. Inflamm Bowel Dis. 2008 Jan;14(1):134-5.

10. Does incontinence severity correlate with quality of life? Prospective analysis of 502 consecutive patients. Bordeianou L, Rockwood T, Baxter N, Lowry A, Mellgren A, Parker S.Colorectal Dis. 2008 Mar;10(3):273-9.

11. Controversies in the surgical management of sigmoid diverticulitis. Bordeianou L, Hodin R. J Gastrointest Surg. 2007 Apr;11(4):542-8.

12. Expanding the role of strictureplasty: can resections be made obsolete? Bordeianou L, Hodin RA. Inflamm Bowel Dis. 2005 Sep;11(9):861-2.

13. Focal nodular hyperplasia in a child with Beckwith-Wiedemann syndrome. Bordeianou L, Ryan DP, Goldstein AM. Pediatr Surg Int. 2005 Sep;21(9):742-4.

back to top